Research and Development Bibliography
Papers & Abstracts
Senior, R et al. European Journal of Echocardiography, January 2009: Detection of Coronary Artery Disease with Perfusion Stress Echocardiography Using a Novel Ultrasound Imaging Agent: Two Phase 3 International Trials in Comparison with Radionuclide Perfusion Imaging
Memisoglu, A et al. Circulation, Annual Meeting of the American Heart Association, November 2008. Abstract 4706: Perfusion Stress Echocardiography with Perflubutane Polymer Microspheres Provides Incremental Predictive Value for Coronary Artery Disease Over Clinical Risk Factors.
Dittrich MT, Epperly WC, Kopelen H, Strachan GM, Harden M, Sandelski J, Malhrous H, Belcik T., JDMS September/October 2008 24:286-298: Evaluation and Optimization of Real-time Perfusion Imaging Using Multiple Ultrasound Systems with Imagify Microspheres
Pano, A et al. European Journal of Echocardiography Abstracts Supplement, December 2007. Abstract 716: Evaluation of ECG-related safety of perflubutane polymer microspheres (PPM) injectable suspension is chronic stable angina patients undergoing stress echocardiography in RAMP-1 and -2 trials.
Senior, R et al. Circulation, Annual Meeting of the American Heart Association, November 2007. Abstract 2479: Accurate Detection of Coronary Artery Disease by Echocardiography using Perflubutane Polymer Microspheres, a Novel Contrast Agent: Comparison with Nuclear Perfusion Imaging in Two Phase Three Multicenter Clinical Trials.
Senior, Expert Rev Cardiovasc Ther. 2007; 5: 413-421. Imagify™ (perflubutane polymer microspheres) injectable suspension for the assessment of coronary artery disease
Articles
Bernstein H. Scripps Target, T&F Informa, UK Ltd. 2005. Acusphere: making speciality pharmaceuticals using porous microparticle technology.